Print Page | Contact Us | Report Abuse | Sign In | Register
Diabetes Mellitus Preceptorship at Columbia University
Share |


Columbia University, College of Physicians and Surgeons
New York, New York
John P. Bilezikian, M.D.
Vice-Chair, International Education and Research
Chief Emeritus, Division of Endocrinology
November 13-17, 2017, optional Frontiers Research Conference November 18

 Appy Now

The Preceptorial in Diabetes and Obesity, sponsored by the Endocrine Fellows Foundation, is conducted at the Naomi Berrie Diabetes Center at Columbia University Medical Center.  The faculty that will be conducting this Preceptorship in Diabetes and Obesity is comprised of Drs. John P. Bilezikian, Lauren Golden, Robin Goland, Domenico Accili, Natasha Leibel, Magdalena Bogun, Utpal Pajvani, Wendy Chung, Rudolph Leibel, Xavier Pi-Sunyer, Judith Korner, Blandine Laferrere, Tirissa Reid, Joseph Tenenbaum, Henry Ginsberg, Mishaela Rubin, Daniel Casper, Gerald Appel, Megan Sykes, Dieter Egli.

 

The faculty engages in a vigorous clinical research program as well as in an active practice. The Naomi Berrie Diabetes Center is the site for one of the country’s largest programs of clinical trials in Type 1 diabetes.  These include TrialNet Type 1 Diabetes Pathway to Prevention, Immune Effects of Oral Insulin in Relatives at Risk for Type 1 Diabetes, CTLA-4 Ig for Prevention of Abnormal Glucose Tolerance in Relatives at Risk for Type 1 Diabetes Mellitus, and TUDCA: Clinical Investigation of Efficacy of Taurourodeoxycholic Acid to Enhance Beta Cell Survival in Type 1 Diabetes by Reducing ER Stress.  In addition, Berrie Center researchers participate in the GRADE Study (Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness), TODAY Study of Type 2 Diabetes in Adolescence and Youth, and Skin Biopsies for Generation of Disease-Specific Stem Cells.  Faculty expertise also extends to more fundamental research initiatives, including: beta-cell biology, insulin action and insulin resistance, the genetics of obesity, non-alcoholic steatohepatitis, development of cell replacement therapies in diabetes, in-vivo imaging of beta-cell mass, and modelling of autoimmunity in type 1 diabetes.  Clinical, diagnostic and therapeutic approaches used by the group are on the cutting edge of the field, and in many instances, have been defined by their efforts. 

 

The fellows who are selected to participate in this program will gain experience in all these areas.  Additionally, the preceptorial will consist of regular conferences replete with clinical case discussions, journal club, and research seminars.  The preceptorial will also emphasize heavily the clinical approach to the patient with diabetes and obesity. The diagnostic and therapeutic approach to a wide variety of clinical problems will be reviewed case by case with the fellow.  During the one-week training period, there will be many opportunities to have discussions with many members of the faculty.

 

Agenda

November 13: (Day 1) 1. Welcome & Introduction to Diabetes (Drs. Bilezikian and Golden); 2. The New Biology of Diabetes (Dr. Accili). 3. Type 1 Diabetes: Epidemiology, Pathophysiology, Prevention Trials (Dr. Goland); 4. Medical Management of T1DM (Dr. N Leibel); 5. Hands-On Session: New Pumps/Sensors/Hybrid systems (NBDC CDE’s).

November 14: (Day 2) 6. Challenging Pump and Sensor Downloads (Dr. Golden) 7. Epidemiology and Pathophysiology of Type 2 Diabetes (Dr. Golden); 8. Medical management of Type 2 Diabetes: Orals, Incretins (Dr. Pajvani). 9. Diabetes Case Conference (Berrie Center Faculty). 10. Medical management of Type 2 Diabetes: Insulin (Dr. Bogun). 11. Monogenic Diabetes (Dr. Chung). 12. Diagnostic Dilemmas (Dr. Golden)

November 15: (Day 3) 13. Epidemiology and Pathophysiology of Obesity (Dr. Pi-Sunyer). 14. Role of Intrauterine Environment in Programming of Obesity and Diabetes (Dr. R Leibel).15. Medical Management of Obesity (Dr. Korner). 16. Dewitt-Goodman Seminar in Obesity 17. Surgical Management of Obesity (Dr. Laferrere). 18. New Medications/Trials in Obesity (Dr. Reid)

November 16: (Day 4) 19. Naomi Berrie Diabetes Center Research Conference. 20. Cardiovascular Risk in Diabetes (Dr. Tenenbaum). 21. Medical Management of Lipids in Diabetes (Dr. Ginsberg). 22. NASH (Dr. Pajvani). 23. Diabetes and Bone (Dr. Rubin).

November 17:
(Day 5) 24. Update in Retinopathy (Dr. Casper). 25 Update in Nephropathy (Dr. Appel). 26. Update in Neuropathy (Dr.). 27. Animal Models of T1DM (Dr. Sykes). 28. Novel Therapies in Diabetes (Dr. Egli)

November 18:
(Day 6) Frontiers in Diabetes Research: “Advances and Challenges in the Neuroscience of Ingestive Behaviors”



Speakers are tentative


Application Requirements:

  1. Completed Application Form  
  2. Letter of Support from the program director/mentor (1 page)
  3. Personal letter of Interest from the Fellow being nominated(1 page)
  4. Curriculum Vitae (No Limit) 

Endocrine Fellow Foundation
342 North Main Street, Suite 301
West Hartford, CT 06117-2507
P: 860.586.7574
F: 860.586.7550
info@endocrinefellows.org

The EFF is a 501c(3) non-profit organization whose mission is to foster the advancement of fellows in endocrinology, diabetes and metabolism through mentoring, education, research funding and career support. ©